WO2011096685A3 - 신종플루 바이러스와 조류인플루엔자 바이러스에 대한 불활화능을 가진 약쑥 95%주정추출물이 함유된 쑥환 - Google Patents

신종플루 바이러스와 조류인플루엔자 바이러스에 대한 불활화능을 가진 약쑥 95%주정추출물이 함유된 쑥환 Download PDF

Info

Publication number
WO2011096685A3
WO2011096685A3 PCT/KR2011/000633 KR2011000633W WO2011096685A3 WO 2011096685 A3 WO2011096685 A3 WO 2011096685A3 KR 2011000633 W KR2011000633 W KR 2011000633W WO 2011096685 A3 WO2011096685 A3 WO 2011096685A3
Authority
WO
WIPO (PCT)
Prior art keywords
wormwood
virus
ethyl alcohol
avian influenza
alcohol extract
Prior art date
Application number
PCT/KR2011/000633
Other languages
English (en)
French (fr)
Other versions
WO2011096685A2 (ko
Inventor
조봉관
심희영
Original Assignee
Jo Bongkwan
Shim Heeyoung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jo Bongkwan, Shim Heeyoung filed Critical Jo Bongkwan
Priority to US13/577,106 priority Critical patent/US20120308653A1/en
Publication of WO2011096685A2 publication Critical patent/WO2011096685A2/ko
Publication of WO2011096685A3 publication Critical patent/WO2011096685A3/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282—Artemisia, e.g. wormwood or sagebrush
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

본 발명은 신종플루 바이러스와 조류인플루엔자 바이러스에 대한 불활화 능을 가진 약쑥 95%주정 추출물이 함유된 쑥환에 관한 것으로서, 이를 상세하게 설명하면, 전래 쑥환은 열수 추출한 것으로 조지방성분이 0.8%인데 비하여, 본 발명의 주정 추출 쑥환은 조지방이 11.6%로, 특별히 조지방 성분이 14.5배 높게 추출되었으며, 신종플루(H1N1) 바이러스를 99.99% 불활화 능이, 그리고 조류인플루엔자(H9N2) 바이러스에 대한 소독효력이 각각 나타났다. 본 발명의 신종플루 바이러스와 조류인플루엔자 바이러스에 대한 불활화 능을 가진 약쑥 95%주정 추출물이 함유된 쑥환을 사람이나 가금류에게 투여하여 신종플루 바이러스와 조류인플루엔자 바이러스에 대하여 면역력을 갖도록 하는 것을 특징으로 하는 약쑥 95%주정 추출물이 함유된 쑥환에 관한 것이다.
PCT/KR2011/000633 2010-02-03 2011-01-31 신종플루 바이러스와 조류인플루엔자 바이러스에 대한 불활화능을 가진 약쑥 95%주정추출물이 함유된 쑥환 WO2011096685A2 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/577,106 US20120308653A1 (en) 2010-02-03 2011-01-31 Wormwood pill containing 95% of wormwood ethyl alcohol extract that has inactivation efficacy of the h1n1 virus and the h9n2 avian influenza virus

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020100009824A KR101177182B1 (ko) 2010-02-03 2010-02-03 신종플루 바이러스와 조류인플루엔자 바이러스에 대한 불활화 능을 가진 약쑥 95%주정추출물이 함유된 쑥환
KR10-2010-0009824 2010-02-03

Publications (2)

Publication Number Publication Date
WO2011096685A2 WO2011096685A2 (ko) 2011-08-11
WO2011096685A3 true WO2011096685A3 (ko) 2011-12-01

Family

ID=44355933

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/000633 WO2011096685A2 (ko) 2010-02-03 2011-01-31 신종플루 바이러스와 조류인플루엔자 바이러스에 대한 불활화능을 가진 약쑥 95%주정추출물이 함유된 쑥환

Country Status (3)

Country Link
US (1) US20120308653A1 (ko)
KR (1) KR101177182B1 (ko)
WO (1) WO2011096685A2 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112043740B (zh) * 2020-09-21 2021-09-24 福建贝迪药业有限公司 一种太子参须提取物在制备抑制鸭h9n2亚型禽流感病毒药物中的应用
KR102278545B1 (ko) * 2021-03-15 2021-07-16 홍성창 항바이러스 효과가 우수한 천연 항바이러스 조성물 및 그 제조방법
KR20240045546A (ko) 2022-09-30 2024-04-08 (주)예스킨 항 인플루엔자 바이러스제

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100346610B1 (ko) * 1994-12-28 2002-11-23 주식회사 엘지씨아이 스코폴레틴을포함하는비형간염치료제
KR20060042298A (ko) * 2004-11-09 2006-05-12 한국생명공학연구원 절지동물용 항바이러스 조성물
JP2007191480A (ja) * 2006-01-20 2007-08-02 Livzon Pharmaceutical Group Inc 鳥インフルエンザの治療のための漢方組成物、それらの調製方法、およびそれらの適用
KR20090010248A (ko) * 2009-01-07 2009-01-29 지엘팜텍 주식회사 애엽 추출물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006033496A1 (en) * 2004-09-24 2006-03-30 Ben's Lab Co., Ltd. Functional composition for the prevention and alleviation of hangover

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100346610B1 (ko) * 1994-12-28 2002-11-23 주식회사 엘지씨아이 스코폴레틴을포함하는비형간염치료제
KR20060042298A (ko) * 2004-11-09 2006-05-12 한국생명공학연구원 절지동물용 항바이러스 조성물
JP2007191480A (ja) * 2006-01-20 2007-08-02 Livzon Pharmaceutical Group Inc 鳥インフルエンザの治療のための漢方組成物、それらの調製方法、およびそれらの適用
KR20090010248A (ko) * 2009-01-07 2009-01-29 지엘팜텍 주식회사 애엽 추출물

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J.-P. YONG: "Synthesis of rupestonic acid amide derivatives and in vitro anti-influenza A3, B and herpes simplex type I and II viruses", CHINESE JOURNAL OF ORGANIC CHEMISTRY, vol. 28, no. 10, 2008, pages 1807 - 1812 *

Also Published As

Publication number Publication date
KR20110090186A (ko) 2011-08-10
WO2011096685A2 (ko) 2011-08-11
KR101177182B1 (ko) 2012-08-24
US20120308653A1 (en) 2012-12-06

Similar Documents

Publication Publication Date Title
TN2013000485A1 (en) 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
WO2011103453A3 (en) Vaccines for use in the prophylaxis and treatment of influenza virus disease
TN2015000185A1 (en) 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
MX2022009352A (es) Sal de hemisulfato de nucleotido para el tratamiento del virus de hepatitis c.
NZ629996A (en) 2’- substituted carba-nucleoside analogs for antiviral treatment
MY182771A (en) Viral replication inhibitors
EP2538946A4 (en) ANTIVIRAL FORMULATIONS
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
PH12015502230A1 (en) Novel viral replication inhibitors
WO2011076367A3 (en) Synergistic antiviral composition and use thereof
WO2012144754A3 (ko) 바이러스 억제 효능을 갖는 오배자 추출물 또는 이로부터 분리된 화합물을 유효성분으로 함유하는 조성물 및 이의 용도
SG179082A1 (en) Method for the preparation of an influenza virus
MX2013012233A (es) 4-aril-n-fenil-1,3,5-triazin-2-aminas sustituidas.
AU2011280259A8 (en) Influenza vaccine
WO2012093234A3 (fr) Arabinogalactanes sulfates, apiogalacturonanes et heteroglycanes sulfates pour le traitement des maladies causees par les virus influenza
ES2524385R1 (es) Composición farmacéutica y su uso para preparar un medicamento destinado al tratamiento y la prevención de enfermedades causadas por el VIH
EP2788311A4 (en) COMPOSITION COMPRISING PIN NEEDLE EXTRACT OR COMPOUNDS ISOLATED THEREFROM FOR THE PREVENTION AND TREATMENT OF CANCER DISEASE BY INHIBITING PAPILLOMAVIRUS VIRUS (HPV) AND USES THEREOF
MX2015014309A (es) Modulador de sabor y metodo para utilizar el mismo.
WO2011096685A3 (ko) 신종플루 바이러스와 조류인플루엔자 바이러스에 대한 불활화능을 가진 약쑥 95%주정추출물이 함유된 쑥환
WO2011118957A3 (ko) 파프리카 추출물을 함유하는 염증, 알레르기 또는 천식 질환 치료용 조성물
CU20110181A7 (es) Composición para el control de patógenos
WO2013173256A3 (en) New and improved influenza vaccines
WO2009117736A3 (en) Avian virus vaccines and uses thereof
WO2013109202A3 (en) Pharmaceutical compounds comprising cefetamet
WO2011005043A3 (ko) 울금 추출물을 포함하는 인플루엔자 바이러스 감염의 예방 및 치료용 조성물 및 뉴라미니데이즈 활성의 억제용 조성물

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11739981

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 13577106

Country of ref document: US

122 Ep: pct application non-entry in european phase

Ref document number: 11739981

Country of ref document: EP

Kind code of ref document: A2